Flora Growth Corp. (FLGC) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
3230 W. COMMERCIAL BOULEVARD FORT LAUDERDALE, FL 33309 |
| State of Incorp. | ON |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 3/31/2024 MRQ | 12/31/2023 | 12/31/2022 | |||
|---|---|---|---|---|---|
| ASSETS | |||||
| Current Assets | |||||
| Cash, cash equivalents, and short-term investments | 4,350 | 9,537 | |||
| Cash and cash equivalents | 4,350 | 9,537 | |||
| Restricted cash and investments | 35 | ||||
| Receivables | 3,950 | 6,851 | |||
| Inventory, net of allowances, customer advances and progress billings | 8,508 | 10,089 | |||
| Inventory | 8,508 | 10,089 | |||
| Other undisclosed current assets | 4,521 | 4,678 | |||
| Total current assets: | 21,364 | 31,155 | |||
| Noncurrent Assets | |||||
| Operating lease, right-of-use asset | 389 | 2,537 | |||
| Property, plant and equipment | 847 | 4,810 | |||
| Intangible assets, net (including goodwill), including: | 946 | 41,468 | |||
| Goodwill | (23,372) | 23,372 | |||
| Intangible assets, net (excluding goodwill) | 946 | 18,096 | |||
| Other undisclosed intangible assets, net (including goodwill) | 23,372 | ||||
| Other noncurrent assets | 80 | ||||
| Other undisclosed noncurrent assets | 1,017 | ||||
| Total noncurrent assets: | 2,262 | 49,832 | |||
| TOTAL ASSETS: | 23,626 | 80,987 | |||
| LIABILITIES AND EQUITY | |||||
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,955 | 7,748 | |||
| Accounts payable | 5,111 | 7,748 | |||
| Accrued liabilities | 1,844 | ||||
| Debt | 1,931 | 1,086 | |||
| Business combination, contingent consideration, liability | 1,095 | ||||
| Other liabilities | 799 | ||||
| Other undisclosed current liabilities | 5,500 | 8,613 | |||
| Total current liabilities: | 16,280 | 17,447 | |||
| Noncurrent Liabilities | |||||
| Liabilities, other than long-term debt | 942 | 3,581 | |||
| Deferred income tax liabilities | 1,712 | ||||
| Operating lease, liability | 942 | 1,869 | |||
| Other undisclosed noncurrent liabilities | 3,547 | ||||
| Total noncurrent liabilities: | 942 | 7,128 | |||
| Total liabilities: | 17,222 | 24,575 | |||
| Commitments and contingencies | 5,500 | 5,044 | |||
| Temporary equity, carrying amount | (5,500) | (5,044) | |||
| Equity | |||||
| Equity, attributable to parent | 6,404 | 56,823 | |||
| Additional paid in capital | 149,093 | 150,420 | |||
| Accumulated other comprehensive loss | (140) | (2,732) | |||
| Accumulated deficit | (142,549) | (90,865) | |||
| Equity, attributable to noncontrolling interest | (411) | ||||
| Total equity: | 6,404 | 56,412 | |||
| TOTAL LIABILITIES AND EQUITY: | 23,626 | 80,987 | |||
Income Statement (P&L) ($ in thousands)
| 3/31/2024 TTM | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|
| Revenues | 76,071 | 37,171 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (58,333) | (22,757) | ||
| Gross profit: | 17,738 | 14,414 | ||
| Operating expenses | (68,092) | (67,721) | ||
| Operating loss: | (50,354) | (53,307) | ||
| Nonoperating income (expense) (gain, Foreign Currency Transaction, before Tax) | 158 | 323 | ||
| Interest and debt expense | (236) | (1,607) | ||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | ||||
| Loss from continuing operations before equity method investments, income taxes: | (50,432) | (54,591) | ||
| Other undisclosed income from continuing operations before income taxes | 2,135 | 424 | ||
| Loss from continuing operations before income taxes: | (48,297) | (54,167) | ||
| Income tax benefit | 1,628 | 1,538 | ||
| Loss from continuing operations: | (46,669) | (52,629) | ||
| Loss from discontinued operations | (9,678) | |||
| Other undisclosed net income | 105,258 | |||
| Net income (loss): | (56,347) | 52,629 | ||
| Net loss attributable to noncontrolling interest | (689) | |||
| Other undisclosed net loss attributable to parent | (105,258) | |||
| Net loss available to common stockholders, diluted: | (57,036) | (52,629) | ||
Comprehensive Income ($ in thousands)
| 3/31/2024 TTM | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|
| Net income (loss): | (56,347) | 52,629 | ||
| Other comprehensive loss | (300) | |||
| Other undisclosed comprehensive income (loss) | 2,592 | (106,582) | ||
| Comprehensive loss: | (53,755) | (54,253) | ||
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | (689) | 214 | ||
| Comprehensive loss, net of tax, attributable to parent: | (54,444) | (54,039) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.